Spots Global Cancer Trial Database for metastatic bladder cancer
Every month we try and update this database with for metastatic bladder cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel | NCT01814150 | Metastatic Lung... Metastatic Brea... Metastatic Gast... Metastatic Pros... Metastatic Blad... | 18 Years - | Meir Medical Center | ||
| Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies | NCT02030067 | Solid Tumor Metastatic Blad... | RX-3117 | 18 Years - | Processa Pharmaceuticals | |
| A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer | NCT01454089 | Urologic Neopla... Metastatic Blad... Urinary Tract N... | OGX-427 600 mg OGX-427 1000 mg Placebo Gemcitabine Cisplatin Carboplatin | 18 Years - | Achieve Life Sciences | |
| A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer | NCT01454089 | Urologic Neopla... Metastatic Blad... Urinary Tract N... | OGX-427 600 mg OGX-427 1000 mg Placebo Gemcitabine Cisplatin Carboplatin | 18 Years - | Achieve Life Sciences | |
| A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer | NCT05699135 | Urinary Bladder... Bladder Cancer Bladder Tumors Urothelial Carc... | Avelumab first-... | 18 Years - | Pfizer | |
| The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel | NCT01814150 | Metastatic Lung... Metastatic Brea... Metastatic Gast... Metastatic Pros... Metastatic Blad... | 18 Years - | Meir Medical Center | ||
| A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer | NCT05699135 | Urinary Bladder... Bladder Cancer Bladder Tumors Urothelial Carc... | Avelumab first-... | 18 Years - | Pfizer | |
| Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients | NCT02028442 | Solid Tumours o... Metastatic Colo... Metastatic Blad... | Enadenotucirev | 18 Years - | Akamis Bio | |
| A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing | NCT06129084 | Metastatic Blad... Metastatic Urot... | FGFR Testing | 18 Years - | British Columbia Cancer Agency | |
| A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer | NCT02989584 | Bladder Cancer Metastatic Blad... Urothelial Carc... | Atezolizumab Gemcitabine Cisplatin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients | NCT02028442 | Solid Tumours o... Metastatic Colo... Metastatic Blad... | Enadenotucirev | 18 Years - | Akamis Bio | |
| Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies | NCT02030067 | Solid Tumor Metastatic Blad... | RX-3117 | 18 Years - | Processa Pharmaceuticals |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
